Latest Mesenchymal stem cell Stories
The company aims to increase the market penetration of its proprietary MSC-based research products, while expanding its stem cell segment to include differentiated cells derived from MSCs MOUNTAIN
Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases,
SHENZHEN, China, July 10, 2014 /PRNewswire/ -- Beike Biotechnology Co., Ltd.
Medication and minimally invasive surgery to implant a sling can provide relief for millions of people who suffer from stress urinary incontinence (SUI), but not everyone responds to these therapeutic
Stem cell scientists had what first appeared to be an easy win for regenerative medicine when they discovered mesenchymal stem cells several decades ago.
Positions Company to Participate in One of the Fastest Growing Areas of Stem Cell Research LAS VEGAS, June 25, 2014 /PRNewswire/ -- Cord Blood America, Inc.
Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
Company to Present at BIO International Convention 2014 LOS ANGELES, June 17, 2014 /PRNewswire/ -- MAX BioPharma (www.maxbiopharma.com)announced
FARMINGTON, Conn., June 5, 2014 /PRNewswire/ -- ImStem Biotechnology, Inc. (ImStem) announced today it has successfully
Insception Lifebank, Canada's largest cord blood program, now offers expecting parents the option to bank a section of the actual umbilical cord tissue, in addition to banking cord blood.
- Withering but not falling off, as a blossom that persists on a twig after flowering.